Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{155020,
        author = {Keerthi G S Nair and Anuraj J and Athira S and P Manoj Kumar},
        title = {Precision medicine approach to discover the effective therapy for Hydroxychloroquine No respondents in COVID-19},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {8},
        number = {12},
        pages = {1228-1229},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=155020},
        abstract = {The world is gearing up to battle against the Coronavirus disease 19 (COVID-19) outbreak which has already led to more than 323,256 deaths and 4,893,186 confirmed cases globally as on May 22, 2020 [1]. There are currently no drugs licensed for the treatment or prevention of COVID-19. While several drug trials are ongoing, advisories were published on the use of hydroxychloroquine as prophylaxis for SARS-CoV-2 infection [2-4]. The existence of hydroxychloroquine failure was even recorded in many cases [5] and that is to be suggested for the resistance developed.},
        keywords = {},
        month = {},
        }